Provectus Pharmaceuticals

From Wikipedia, the free encyclopedia

There are very few or no other articles that link to this one.
Please help introduce links in articles on related topics. After links have been created, remove this message.
This article has been tagged since November 2006.

Provectus Pharmaceuticals (NYSE: PVCT) is a biotechnology firm involved in the pursuit of new cancer treatments, including those for breast cancer, liver cancer, and metastatic melanoma. In addition, Provectus has entered stage II clinical trials for a new topical psoriasis treatment.

Their development pipeline includes Provecta, an agent that trials have shown to be "retained in tumor cells while leaving normal tissue unharmed, thereby killing the tumor cells and sparing healthy tissue."

[edit] References

[edit] External links


This biotechnology article is a stub. You can help Wikipedia by expanding it.
This article about a United States corporation or company is a stub. You can help Wikipedia by expanding it
Retrieved from "http://en.wikipedia.org../../../p/r/o/Provectus_Pharmaceuticals_4748.html"